Indiplon-MR: NBIX started the double-blind, placebo-controlled international Phase III SLEEP trial in 600 patients. Secondary endpoints include sleep quality, n

Neurocrine Biosciences Inc. (NBIX), San Diego, Calif. Product: Indiplon-MR ( NBI-34060-MR) Business: Neurological Therapeutic category: Receptor agonist Target: GABA(A) receptor Description: Modified ...